Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,506 | 45,791 | 45,290 | N/A | N/A |
| Marketable Securities | 177,622 | 94,407 | 6,011 | N/A | N/A |
| Receivables | 7,210 | 391 | 487 | N/A | N/A |
| TOTAL | $234,395 | $145,453 | $53,094 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,471 | 4,532 | 4,197 | N/A | N/A |
| Investments And Advances | 54,312 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 872 | 1,063 | 2,553 | 0 | 0 |
| TOTAL | $60,655 | $5,595 | $6,750 | $N/A | $N/A |
| Total Assets | $295,050 | $151,048 | $59,844 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,904 | 9,247 | 7,491 | 0 | 0 |
| Accrued Expenses | 14,289 | 10,121 | 7,389 | N/A | N/A |
| Other current liabilities | 1,249 | N/A | N/A | N/A | N/A |
| TOTAL | $34,609 | $42,093 | $34,305 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,619 | 17,636 | 12,278 | N/A | N/A |
| Deferred Revenues | 1,616 | 16,959 | 11,958 | N/A | N/A |
| Other Non-Current Liabilities | 1,238 | 2,487 | 159,413 | 0 | 0 |
| TOTAL | $36,900 | $37,185 | $195,830 | $N/A | $N/A |
| Total Liabilities | $71,509 | $79,278 | $230,135 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,356 | 3,579 | N/A | N/A | N/A |
| Common Shares | 43 | 36 | 2 | N/A | N/A |
| Retained earnings | -205,866 | -236,514 | -177,725 | N/A | N/A |
| Other shareholders' equity | -167 | -20 | 0 | 0 | 0 |
| TOTAL | $223,541 | $71,770 | $-170,291 | $N/A | $N/A |
| Total Liabilities And Equity | $295,050 | $151,048 | $59,844 | $0 | $0 |